Centre Francois Baclesse

This study tested a combination of chemotherapy drugs (platinum and pemetrexed) plus an immunotherapy drug (atezolizumab), with or without another drug (bevacizumab), in 150 people with advanced non-squamous lung cancer that has specific gene changes (EGFR, ALK, or ROS1) and has …

This study tested the chemotherapy drug carboplatin in 16 men with advanced prostate cancer that no longer responds to hormone therapy. The cancer had specific gene changes that might make it sensitive to carboplatin. The goal was to see if the drug could shrink tumors or lower P…

This study tested whether adding the immunotherapy drug spartalizumab to standard chemotherapy (FLOT) before and after surgery could help people with resectable stomach cancer. 67 adults with early-stage, operable stomach or gastroesophageal junction cancer received the combinati…

This study tested whether auriculotherapy (a type of ear acupuncture) can reduce joint and muscle pain caused by aromatase inhibitors, a common breast cancer hormone therapy. About 197 postmenopausal women with breast cancer who had pain for at least 3 months were randomly assign…

This study tested a virtual reality program to help breast cancer patients who have memory or concentration problems after treatment. 23 patients used the program for 10-15 minutes each week for 6 weeks. The goal was to see if patients would stick with the program and if it could…

This study tested whether using a virtual reality headset with a relaxation app could lower anxiety in people about to have their thyroid removed due to cancer. 82 adults used the headset before surgery, and researchers measured their stress levels before and after. The goal was …

This study tested a special education program to help cancer patients manage their pain better. 167 patients took part, with some getting the program and others receiving usual care. The goal was to see if learning about pain and its treatment could reduce how much pain interfere…

This study looked at whether a special walking platform, designed to prevent falls and help with standing, could be used by older cancer patients (over 70) while they were in the hospital. The goal was to see if patients would use it enough to make it a practical option. The stud…

This study tested whether adding a telemonitoring app (Cureety) to standard care could reduce the number of phone calls hospital staff need to make to patients receiving injectable cancer treatments. 192 adults starting injectable anticancer therapy participated. The app collecte…

This study looked at 300 adults receiving their first round of chemotherapy for cancer. Researchers wanted to understand why some patients still experience nausea and vomiting even when given standard anti-nausea medicines. Participants filled out questionnaires to track their sy…

This study looked at how chemotherapy affects the overall quality of life in women treated for stage II or III endometrial cancer. Researchers surveyed 51 women at least two years after their treatment ended, using standard questionnaires to measure physical, emotional, and socia…